Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05982561
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Sponsor: Early is Good Inc.
View on ClinicalTrials.gov
Summary
BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer. This prospective, blinded study evaluates its efficacy in detecting recurrent NMIBC, offering a noninvasive monitoring solution.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2023-07-26
Completion Date
2025-12-31
Last Updated
2024-04-10
Healthy Volunteers
No
Conditions
Locations (3)
Arkansas Urology Research Center
Little Rock, Arkansas, United States
Indiana University School of Medicine
Indianapolis, Indiana, United States
Washington University
St Louis, Missouri, United States